SCHEMBL8869769

SCHEMBL8869769

CCOC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCCc3ccccc3)cc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.48
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 1/20 0.42
MLYCD O95822 1/20 0.42
EPHX2 P34913 1/20 0.42
PPARA Q07869 1/20 0.42
CA2 P00918 1/20 0.42
CNR1 P21554 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
KCNH2 Q12809 1/20 0.41
SCN5A Q14524 1/20 0.41
SCN9A Q15858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869243 0.97 P4HTM (0.47) P4HTMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8868669 0.95 P4HTM (0.49) P4HTMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8869197 0.93 NPC1 (0.46) P4HTMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8867891 0.92 P4HTM (0.48) P4HTMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8868326 0.92 P4HTM (0.50) P4HTMNPC1RAB9ASMN1; SMN2MLYCD
SCHEMBL8867435 0.91 NPC1 (0.46) P4HTMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8869875 0.90 P4HTM (0.48) P4HTMNPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8870171 0.90 P4HTM (0.49) P4HTMNPC1RAB9ASMN1; SMN2MLYCD
SCHEMBL8869654 0.90 P4HTM (0.51) P4HTMEPHX2CA2
SCHEMBL9141434 0.90 P4HTM (0.51) P4HTMNPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed